Coeliac Centre/First Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Italy.
J Clin Gastroenterol. 2012 Jan;46(1):46-50. doi: 10.1097/MCG.0b013e318221077e.
HLA-DQB1*02 homozygosity was shown to be more common in patients with complicated rather than uncomplicated celiac disease (CD).
To study HLA-DQA1 and DQB1 profile in adult patients with different forms of CD, including patients with complicated and potential CD, the most affected and the most preserved histologic end of the pathologic celiac spectrum.
HLA-DQA1 and DQB1 molecular typing was performed in 218 adult CD patients (169 with uncomplicated CD, 27 with complicated CD, and 22 with potential CD) and 224 healthy stem cell donors. HLA-DQA1 and DQB1 gene polymorphism was analyzed using polymerase chain reaction sequence-specific primers and/or reverse polymerase chain reaction sequence-specific oligonucleotides techniques.
As expected, the frequency of HLA-DQB102 allele, DQB102 homozygosity, and DQB10302 gene were statistically different in the 4 groups. However, multivariate analysis demonstrated that patients with potential CD have a higher frequency of both HLA-DQB10302 and HLA-DQB10603 alleles and a reduced frequency of DQB102 homozygosity compared with patients with uncomplicated and complicated CD.
The increased frequency of DQB10302 and the reduced frequency of DQB102 homozygosity in potential CD is consistent with the idea that different clinical/pathologic evolutions might be related to different immunogeneses. This could be clinically relevant in the future.
与单纯性乳糜泻(CD)相比,HLA-DQB1*02 纯合子在复杂性 CD 患者中更为常见。
研究不同类型 CD 成年患者的 HLA-DQA1 和 DQB1 表型,包括复杂性和潜在性 CD 患者,以及病理乳糜泻谱中受影响最严重和最保存的组织学末端。
对 218 例成年 CD 患者(169 例单纯性 CD,27 例复杂性 CD,22 例潜在性 CD)和 224 名健康干细胞供体进行 HLA-DQA1 和 DQB1 分子分型。采用聚合酶链反应序列特异性引物和/或反向聚合酶链反应序列特异性寡核苷酸技术分析 HLA-DQA1 和 DQB1 基因多态性。
正如预期的那样,4 组间 HLA-DQB102 等位基因、DQB102 纯合子和 DQB10302 基因的频率存在统计学差异。然而,多变量分析表明,与单纯性和复杂性 CD 患者相比,潜在性 CD 患者 HLA-DQB10302 和 HLA-DQB10603 等位基因的频率更高,而 DQB102 纯合子的频率更低。
潜在性 CD 中 DQB10302 的频率增加和 DQB102 纯合子的频率降低与不同的临床/病理演变可能与不同的免疫发生有关的观点一致。这在未来可能具有临床相关性。